Contact Sales

Pharma manufacturers face the problem of paying unauthorized rebates to third-party payers for prescriptions bought at a 340B discount.

Pharmacist checking prescription inventory

Companies are increasingly challenged with automating and paying multi-tier channels and indirect partners

  • No simple linkage between sales and dispensing transactions means companies cannot easily determine if stock was acquired at 340B prices.
  • As part of rebate contracts, payers submit transactions that were dispensed by pharmacies using product acquired at 340B prices.
  • With heavy discounting and penny pricing, manufacturers may pay more in discounts than the drug’s original price, albeit to multiple entities.
Pharmacist checking prescription inventory

The benefits of Model N 340B Vigilance

Model N 340B Vigilance helps reduce the problem of duplicate discounts.


Optimize revenue

Reduce revenue loss caused by duplicate discounts between 340B and payer and/or Medicaid claims.

data grid

Ensure compliance

Continuously monitor compliance with the 340B Drug Pricing Program.


Gain insights

Gain insights and control over 340B discounts and policy.

Product Features

Third-party integrations

Integrated with leading 340B vendors to identify duplicate discount script transactions.

Definitive transaction data submissions

Covered entities are notified of any instances of duplicate Medicaid rebates and given the opportunity to correct actions and improve 340B program integrity.

Enhanced checks and reporting

Expands the validation capabilities already performed within Validata, enabling more accurate identification of ineligible rebate claims.


Powering Innovators

Enabling our Customers to Deliver Life-Changing Products to the World


Start typing and press Enter to search